Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Deferred Tax Assets (2013 - 2016)

Iradimed (IRMD) reported Current Deferred Tax Assets of -$311871.0 for Q4 2016, down 320.49% year-over-year from $141446.0 in Q1 2016, and down 198.16% on a QoQ basis from $317709.0 in Q3 2016.

Iradimed (IRMD) has 4 years of Current Deferred Tax Assets data on file, last reported at -$311871.0 in Q4 2016.

  • Quarterly Current Deferred Tax Assets fell 320.49% year-over-year to -$311871.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$311871.0 (down 320.49% YoY) and the FY2016 annual result came in at -$311871.0, down 320.49% from the prior year.
  • Current Deferred Tax Assets fell to -$311871.0 in Q4 2016 per IRMD's latest filing, from $317709.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $338634.0 in Q1 2016 and bottomed at -$311871.0 in Q4 2016.
  • The 4-year median for Current Deferred Tax Assets is $144930.5 (2015), against an average of $137450.8.
  • The widest annual swing landed in 2015, when Current Deferred Tax Assets surged 215.69%; it then sank 320.49% in 2016.
  • Tracing IRMD's Current Deferred Tax Assets over 4 years: stood at $65961.0 in 2013, then jumped by 76.38% to $116339.0 in 2014, then gained by 21.58% to $141446.0 in 2015, then slumped by 320.49% to -$311871.0 in 2016.
  • Per Business Quant, the three latest IRMD Current Deferred Tax Assets figures stand at -$311871.0 (Q4 2016), $317709.0 (Q3 2016), and $320587.0 (Q2 2016).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Iradimed 1.17 Bn 1.11 Bn 16.81 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 -311,871.00
Dec 31, 2016 -311,871.00
Sep 30, 2016 317,709.00
Sep 30, 2016 317,709.00
Jun 30, 2016 320,587.00
Jun 30, 2016 320,587.00
Mar 31, 2016 338,634.00
Mar 31, 2016 338,634.00
Dec 31, 2015 141,446.00
Dec 31, 2015 141,446.00
Sep 30, 2015 174,403.00
Sep 30, 2015 174,403.00
Jun 30, 2015 204,949.00
Jun 30, 2015 204,949.00
Mar 31, 2015 148,415.00
Mar 31, 2015 148,415.00
Dec 31, 2014 116,339.00
Dec 31, 2014 116,339.00
Sep 30, 2014 67,916.00
Sep 30, 2014 67,916.00
Jun 30, 2014 64,921.00
Jun 30, 2014 64,921.00
Dec 31, 2013 65,961.00
Dec 31, 2013 65,961.00